Quantcast
Last updated on April 17, 2014 at 10:14 EDT

Latest Attention-deficit hyperactivity disorder management Stories

2012-02-03 11:56:50

Mayo Clinic researchers have found that multiple exposures to anesthesia at a young age are associated with higher rates of attention-deficit/hyperactivity disorder (ADHD). Children exposed to two or more anesthetics before age 3 had more than double the incidence of ADHD than children who had no exposure, says David Warner, M.D., a Mayo Clinic pediatric anesthesiologist and investigator on the observational study. The findings are published in the Feb. 2 edition of Mayo Clinic...

2012-01-09 13:40:46

Reports new study in Journal of the American Academy of Child and Adolescent Psychiatry While pharmacologic agents have a demonstrated efficacy in children with Attention-deficit/hyperactivity disorder (ADHD), some children have suboptimal response to a single pharmacologic agent. A recent study by Dr. Timothy E. Wilens and colleagues, published in the January 2012 issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), is the first randomized...

2012-01-05 08:00:00

The Drake Institute of Behavioral Medicine in southern California has applied a new neurofeedback technology in the treatment of Attention Deficit Hyperactivity Disorder patients that is enabling ADHD patients to achieve more rapidly the normalization of brain wave activity. This improvement into more coherent and harmonious brainwave activity reduces ADHD symptoms, and reduces the need for medication. Irvine, California (PRWEB) January 05, 2012 The Drake Institute of Behavioral Medicine...

2012-01-05 07:00:00

NYON, Switzerland, January 5, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the acceptance for review of their once-daily ADHD medicinal product Venvanse(R) (lisdexamfetamine dimesylate) by the Medicines Healthcare products Regulatory Agency (MHRA), UK. The MHRA have agreed to act as the Reference Member State for this Decentralised Procedure (DCP) which will initially include eight European...

Poverty And Diabetes Leads To Higher Risk Of ADHD
2012-01-03 14:18:02

Researchers at Queens College and Mount Sinai School of Medicine have found that low socioeconomic status (SES) and maternal gestational diabetes may cause a 14-fold increased risk of attention deficit hyperactivity disorder (ADHD) in six-year-olds. Researchers evaluated 212 children at age three or four and again at age six.  They compared 115 children who had low SES, maternal gestational diabetes, or both, to 97 children who had neither. They found that while maternal...

2012-01-02 23:12:01

In the first study of its kind, researchers at Queens College and Mount Sinai School of Medicine have found that low socioeconomic status (SES) and maternal gestational diabetes together may cause a 14-fold increased risk of attention deficit hyperactivity disorder (ADHD) in six year olds. The data are published in the January issue of the Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals. Led by Jeffrey M. Halperin, PhD, Distinguished Professor of...

ADHD Drugs Do Not Up Risk For Heart Problems
2011-12-13 06:15:34

Researchers, funded by the U.S. Food and Drug Administration and the Agency for Health Research Quality, recently studied the cardiovascular risk of ADHD medications in adults. The study found little evidence that the medications increased the risk of heart events, such as heart attack, sudden cardiac death, and stroke. The concerns stem from the fact that some of the medications are able to slightly increase heart rate and blood pressure levels. According to the study,...

2011-12-12 07:00:00

OAKLAND, Calif., Dec. 12, 2011 /PRNewswire/ -- Researchers have found little evidence of increased risk of heart attack, sudden cardiac death or stroke associated with use of medications used primarily to treat attention deficit hyperactivity disorder. Their population-based study included more than 150,000 adults aged 25-64 years who used ADHD medications. This new study, funded by the U.S. Food and Drug Administration and the Agency for Health Research Quality, is the largest --...

2011-12-05 13:08:11

Children's Hospital of Philadelphia research suggests that interventions at the glutamate transmission level might treat disorder Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene...

2011-12-04 12:00:00

--Children's Hospital of Philadelphia Research Suggests that Interventions at the Glutamate Transmission Level Might Treat Disorder-- PHILADELPHIA, Dec. 4, 2011 /PRNewswire-USNewswire/ -- Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for...